Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus.
Marin JacobwitzCaitlyn MulvihillMichael C KaufmanAlexander K GonzalezKarla ResendizJennifer M MacDonaldConall FrancoeurIngo HelbigAlexis A TopjianNicholas S AbendPublished in: Neurology (2022)
This study provides Class IV evidence on the therapeutic utility of ketamine for treatment of RSE in children and neonates.